Pain & Numbness
in your feet, legs or hands?
Afraid of losing your balance?
What Is Peripheral Neuropathy?
Nerves located outside of the brain and spinal cord are referred to as the peripheral nervous system. These nerves are responsible for supplying messages to and from organs, muscles and sensory receptors in our skin and joints. The term ‘Peripheral Neuropathy’ (PN) is used to describe the condition when one (mononeuropathy) or several (polyneuropathy) of these nerves becomes damaged.
PN is most commonly found in persons suffering with diabetes, but can also be caused by other factors including trauma, HIV, infection, autoimmune diseases (eg. RA, lupus), alcohol abuse, certain drugs (eg. statins), and cancer chemotherapy.
Most commonly, the hands and feet are affected causing symptoms such as:
hyper-sensitivity to touch or to hot
and cold, impaired balance
difficulty sleeping due to leg
and foot discomfort
Treating the underlying condition may relieve some cases of PN. In many instances in the past, however, people suffered with their pain as no effective and satisfactory treatment was available. Recent advances in medicine and our understanding of how these sensory nerves are able to heal and regenerate has led to the development of a new treatment involving the use of monochromatic infrared light (MIR) therapy. Multiple studies have shown significant improvements in sensation, and a reduction in pain, numbness and burning in peripheral neuropathy patients treated with MIR therapy.
A Clinically Proven Protocol Published In The Journal
Of The Podiatric Medical Association
In 2005, the Journal of the Podiatric Medical Association8 published a study involving 1033 patients with peripheral neuropathy who showed a significant and dangerous loss of sensation in their feet. The majority of those treated with MIR therapy, in this study, regained protective sensation in their feet making them less prone to falls, less likely to lose their mobility, and greatly reducing the risk for developing wounds that won’t heal and the need for lower extremity amputations.
Since that important study in 2005, several other studies have confirmed the benefits of MIR therapy (see research on the last page).
While drugs are sometimes effective for pain associated with PN, no drug or medical device has previously been shown to increase sensation once it has been diminished or lost due to PN. This is welcome news to the healthcare system where, in the U.S. it costs in excess of 37 billion dollars annually to treat the complications of this condition. This guide explains more about this new treatment.